TriviumVet
Leadership Team

Louise Grubb
CEO and Founder

Louise is former CEO and co-founder of NutriScience (veterinary nutraceutical manufacturing business) and Q1 Scientific (stability storage for the pharmaceutical industry) which was a finalist in the 2016 Ernst & Young EOY Awards. Louise brings over 20 years’ experience of the veterinary and pharmaceutical industry to her role as CEO of TriviumVet. Louise has a track record in bringing veterinary pharmaceuticals through development to regulatory approval and market launch.

Tom Brennan
Chief Operating Officer

Tom has led Pharmaceutical Development as well as Quality and Regulatory functions within IVAX and EirGen Pharma (which he co-founded in 2005). EirGen were acquired by Miami based OPKO Inc. in 2015. Tom holds an MBA, is a Chartered Director and is a Qualified Person as per EU Directive 2001/83. He is co-inventor on a number of pharmaceutical patents.

Liam Fitzgerald
Chairman

Liam Fitzgerald is the former CEO of UDG Healthcare plc, the leading international provider of clinical, commercial, communication, and packaging services to the healthcare industry. During his tenure as CEO from 2000 to 2016, the Company’s market capitalisation increased by more than 500 percent making UGD a member of the FTSE 250 list. Liam is credited with leading and seamlessly integrating more than 30 acquisitions into the parent Company.

TriviumVet Team

Georgina Carpendale
Chief Financial Officer

Georgina, a qualified Chartered Accountant and has over 12 years’ experience in finance and accounting; has operated at C-Suite level in medical device companies, including an ASX listed tech company and has experience in business development, strategic planning, capital raising, structuring strategic partnership opportunities and collaborations internationally.

Gemma Kennedy
Head of Clinical Assurance

Gemma has over 16 years’ experience in the biopharmaceutical and pharmaceutical sector including 10 years with Sanofi where she held key roles in Quality, Regulatory and HR. She holds a first-class honours degree in Chemistry and a Specialist Diploma in Regulatory Affairs.

Dr. Susan Kennedy
Regulatory Affairs Manager

Susan has over 12 years’ experience in academic and translational research environments. Having obtained a PhD in cardiac research from UCD, Susan moved into the oncology field on an international colorectal cancer research project and has numerous peer reviewed publications. Susan has consulted with pharmaceutical companies and academic collaborators in the preparation of key scientific documents including the preparation of regulatory documents for submission to FDA and writing scientific manuscripts for publication in peer reviewed journals.

Dr. Stuart Fitzgerald
Chief Technology Officer

Stuart, a qualified veterinarian, spent over 15 years in companion animal practice in the UK and Ireland. He has worked in pharmaceutical development, as well as managing human and veterinary clinical trials activities. He brings knowledge in the science and economics of companion animal medicine, and experience in aligning clinical and regulatory approaches to new product development.

Serenia Horgan
Head of Quality Assurance

Serenia, is a Qualified Person as per EU Directive 2001/83, with more than 11 years experience leading Quality Assurance and Quality Operations functions in several multinational pharmaceutical and diagnostics companies including Abbott, AbbVie and OPKO, where she managed quality functions for Active Pharmaceutical Ingredients, Oral Solid Dosage Forms and Medical Devices for global markets. She brings a track record of quality excellence and a wealth of practical experience in quality management and customer services as well as a history of implementing and improving quality management systems. Serenia has led numerous FDA and EU health authority inspections throughout her career.

Dr. Robin Flynn
Clinical Affairs Officer

Robin holds a PhD in Veterinary Immunology and has significant experience in research and education having held the position of Associate Professor at the School of Veterinary Medicine & Science at the University of Liverpool where he developed a research team investigating the immunological basis of infectious disease control. He is a Fellow of the Institute of Biomedical Scientists and a significant publication record.

Dr. Liam Byrne
Head of Technical and Business Development

Liam holds a PhD in Analytical Chemistry and is a Chartered Chemist with extensive Business Development experience from his more than 15 years industry experience at senior leadership level in the life sciences industry. Liam has managed teams in Quality Control, Analytical Development and Pharmaceutical Product Development as well as Business Development. He has delivered multiple technically challenging projects from both an R&D and commercialisation perspective. Liam has co-authored a number patents and in 2020, was nominated as a Fellow of the Royal Society of Chemistry based on his extensive career achievements to date.

Sarah O'Connor
Head of Commercial Operations

Sarah has over 12 years’ international project management experience spanning complex multi-cultural teams and holds a Commerce degree from University College Cork. Sarah was Country Programme Manager of the EY Entrepreneur of the Year Ireland for six years and holds a green belt in innovation engineering and a Leadership diploma with Ingenium and the University of Limerick.

Mena Fitzgerald
Office Manager

Mena has over 17 years’ experience as an executive

Scientific Advisory Board

Katie Tolbert

Dr. Tolbert is a leading authority on small animal gastroenterology. She is Clinical Associate Professor of Small Animal Clinical Sciences at Texas A&M University, she also practices as a Clinical Veterinarian in North Carolina State University and is a Veterinary Practice Logistics Liaison to The Dog Aging Project: Funded by the United States National Institute on Aging.

Katies academic publishing CV can be found here.

Matt R. Kaeberlein

Dr. Kaeberlein is recognized internationally for his research on the biological mechanisms of healthy aging. He is a Professor of Pathology at the University of Washington School of Medicine where he directs the Healthy Aging and Longevity Research Institute, the Biological Mechanisms of Healthy Aging Training Program and the NIH Nathan Shock Center of Excellence in the Basic Biology of Aging. Dr. Kaeberlein is a Fellow of the American Association for the Advancement of Science (AAAS), the American Aging Association (AGE), and the Gerontological Society of America (GSA). Dr. Kaeberlein is Co-Director of the Dog Aging Project.

Dr. Kaeberlein’s CV can be found here.

Dean Carolyn J Henry

Dr. Henry was named Dean of the University of Missouri (MU) College of Veterinary Medicine (CVM) in February 2018 after serving as Interim Dean for six months. She is a tenured Full Professor with dual appointments at the CVM and the School of Medicine. She earned her DVM at Auburn University (1990) and practiced small animal and emergency medicine before completing an oncology residency/MS (DACVIM ’94). Henry served on the faculty at Washington State University from 1993 to 1997 before accepting a position at MU in 1997 to develop the oncology service.

Dr. Henry academic publishing CV can be found here.